Top

Gepubliceerd in:

2017 | OriginalPaper | Hoofdstuk

9. Retentio placentae

Auteurs : H. J. van Beekhuizen, J. H. Schagen van Leeuwen

Gepubliceerd in: Obstetrische interventies

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

In het nageboortetijdperk laten placenta en vliezen los en worden uitgedreven. Actief leiden van het na- geboortetijdperk wordt aanbevolen door de Wereldgezondheidsorganisatie (WHO).¹ Actief leiden vermindert het risico op ernstige fluxus post partum (FPP) (> 1000 ml) met een RR van 0,34 (95%-BI 0,14-0,87) [LE A1].¹ Actief leiden vermindert in vergelijking tot het expectatief leiden het aantal retentio placentae (RP) waarvoor een manuele placentaverwijdering (MPV) verricht moet worden echter niet (RR 1,21; 95%-BI 0,82-1,78) [LE A1].¹ RP kan leiden tot ernstige maternale morbiditeit en soms mortaliteit, met name in ontwikkelingslanden.^2-5

vorige hoofdstuk Schouderdystocie

volgende hoofdstuk Placenta accreta, increta en percreta

Begley CM, Gyte GM, Murphy DJ, et al. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2010;(7):CD007412.

Chhabra S, Dhorey M. Retained placenta continues to be fatal but frequency can be reduced. J Obstet Gynaecol. 2002;22:630-3.CrossRef

Onwudiegwu U, Makinde ON. Retained placenta: a cause of reproductive morbidity in Nigeria. J Obstet Gynaecol. 1999;19:355-9.

Owolabi AT, Dare FO, Fasubaa OB, et al. Risk factors for retained placenta in southwestern Nigeria. Singapore Med J. 2008;49:532-7.

Panpaprai P, Boriboonhirunsarn D. Risk factors of retained placenta in Siriraj Hospital. J Med Assoc Thai. 2007;90:1293-7.

Combs CA, Laros RK Jr. Prolonged third stage of labor: morbidity and risk factors. Obstet Gynecol. 1991;77:863-7.

Dombrowski MP, Bottoms SF, Saleh AA, et al. Third stage of labor: analysis of duration and clinical practice. Am J Obstet Gynecol. 1995;172(4, Part 1):1279-84.CrossRef

Mathai M, Gülmezoglu AM, Hill S. WHO guidelines for the management of postpartum haemorrhage and retained placenta. Genève: WHO, 2009.

Adelusi B, Soltan MH, Chowdhury N, Kangave D. Risk of retained placenta: multivariate approach. Acta Obstet Gynecol Scand. 1997;76:414-8.CrossRef

10.

Bais JM, Eskes M, Pel M, et al. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol. 2004;115:166-72.

11.

Cheung WM, Hawkes A, Ibish S, Weeks AD. The retained placenta: historical and geographical rate variations. J Obstet Gynaecol. 2011;31:37-42.CrossRef

12.

Soltan MH, Khashoggi T. Retained placenta and associated risk factors. J Obstet Gynaecol. 1997;17:245-7.

13.

Tandberg A, Albrechtsen S, Iversen OE. Manual removal of the placenta. Incidence and clinical significance. Acta Obstet Gynecol Scand. 1999;78:33-6.PubMed

14.

Titiz H, Wallace A, Voaklander DC. Manual removal of the placenta – a case control study. Aust NZ J Obstet Gynaecol. 2001;41:41-4.CrossRef

15.

Weeks AD. The retained placenta. Best Pract Res Clin Obstet Gynaecol. 2008;22:1103-17.CrossRef

16.

Endler MGC, Saltvedt S. Epidemiology of retained placenta: oxytocin as an independent risk factor. Obstet Gynecol. 2012;119:801-9.CrossRef

17.

Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013;(10):CD001808.

18.

Cotter AM, Ness A, Jorge E. Prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2001;(4):CD001808.

19.

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev. 2007;(2):CD005456.

20.

Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000494.

21.

Leung SW, Ng PS, Wong WY, Cheung TH. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG. 2006;113:1459-64.CrossRef

22.

Deneux-Tharaux C, Macfarlane A, Winter C, et al. Policies for manual removal of placenta at vaginal delivery: variations in timing within Europe. BJOG. 2009;116:119-24.CrossRef

23.

Deneux-Tharaux C, Sentilhes L, Maillard F, et al. Effect of routine controlled cord traction as part of the active management of the third stage of labour on postpartum haemorrhage: multicentre randomised controlled trial (TRACOR). BMJ. 2013;346:f1541.CrossRef

24.

Chongsomchai C, Lumbiganon P, Laopaiboon M. Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. Cochrane Database Syst Rev. 2006;(2):CD004904.

25.

Steins Bisschop CN, Schaap TP, Vogelvang TE, Scholten PC. Invasive placentation and uterus preserving treatment modalities: a systematic review. Arch Gynecol Obstet. 2011;284:491-502.CrossRef

26.

Beekhuizen HJ van, Groot AN de, Boo T de, et al. Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol. 2006;194:446-50.

27.

Johanson R, Cox C, Grady K, Howell C (eds.). Managing obstetric emergencies and trauma; The MOET course manual. 2nd ed. Londen: RCOG, 2007.

28.

Weeks AD, Alia G, Vernon G, et al. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial. Lancet. 2010;375:141-7.CrossRef

29.

Herman A. Complicated third stage of labor: time to switch on the scanner. Ultrasound Obstet Gynecol. 2000;15:89-95.CrossRef

Titel: Retentio placentae
Auteurs: H. J. van Beekhuizen
J. H. Schagen van Leeuwen
Uitgeverij: Bohn Stafleu van Loghum
Boek: Obstetrische interventies
Print ISBN: 978-90-368-1743-1

Elektronisch ISBN: 978-90-368-1744-8

Copyright: 2017
DOI: https://doi.org/10.1007/978-90-368-1744-8_9

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen